FluoGuide A/S (STO:FLUO)
Sweden · Delayed Price · Currency is SEK 33.80
+0.70 (2.11%)
Feb 10, 2026, 4:46 PM CET
FluoGuide Revenue
FluoGuide had revenue of 73.00K DKK in the quarter ending September 30, 2025. This brings the company's revenue in the last twelve months to -475.00K. In the year 2024, FluoGuide had annual revenue of 385.00K, down -8.98%.
Revenue (ttm)
-475.00K DKK
Revenue Growth
-8.98%
P/S Ratio
-785.91
Revenue / Employee
-60.90K DKK
Employees
8
Market Cap
552.61M SEK
Revenue Chart
* This company reports financials in DKK.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 385.00K | -38.00K | -8.98% |
| Dec 31, 2023 | 423.00K | -6.09M | -93.50% |
| Dec 31, 2022 | 6.51M | -3.10M | -32.27% |
| Dec 31, 2021 | 9.61M | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Oncopeptides AB | 62.47M |
| Bio-Works Technologies AB | 46.43M |
| Intervacc AB | 21.09M |
| Elicera Therapeutics AB | 13.70M |
| Corline Biomedical AB | 8.88M |
| Xspray Pharma AB | 3.81M |
| Lipum AB | 398.00K |
| Infant Bacterial Therapeutics AB | -1.00K |